We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USAP
1426
DELISTED
Universal Stainless & Alloy
USAP
$1.7M ﹤0.01%
62,219
-28,095
-31% -$828K
CAAP icon
1427
Corporacion America
CAAP
$4.26B
$1.7M ﹤0.01%
101,974
-64,514
-39% -$1.12M
IMMR icon
1428
Immersion
IMMR
$254M
$1.68M ﹤0.01%
178,859
+124,143
+227% +$1.07M
ASPI icon
1429
ASP Isotopes
ASPI
$475M
$1.67M ﹤0.01%
545,072
+433,734
+390% +$1.67M
CVEO icon
1430
Civeo
CVEO
$376M
$1.66M ﹤0.01%
66,792
-3,838
-5% -$95.6K
D icon
1431
Dominion Energy
D
$62.1B
$1.65M ﹤0.01%
+33,692
New +$1.72M
CLB icon
1432
Core Laboratories
CLB
$493M
$1.64M ﹤0.01%
81,052
-41,819
-34% -$740K
NRC icon
1433
NRC Health Common Stock
NRC
$503M
$1.64M ﹤0.01%
+71,636
New +$2.21M
IXC icon
1434
iShares Global Energy ETF
IXC
$2.68B
$1.63M ﹤0.01%
+39,361
New +$1.69M
EZPW icon
1435
Ezcorp Inc
EZPW
$1.85B
$1.62M ﹤0.01%
+155,114
New +$1.64M
OMCL icon
1436
Omnicell
OMCL
$1.96B
$1.62M ﹤0.01%
+59,972
New +$1.74M
COIN icon
1437
CALL
Coinbase
COIN
$44.2B
$1.62M ﹤0.01%
7,300
-7,800
-52% -$1.79M
PACK icon
1438
Ranpak Holdings
PACK
$550M
$1.62M ﹤0.01%
251,248
-174,052
-41% -$1.18M
COST icon
1439
CALL
Costco
COST
$429B
$1.61M ﹤0.01%
1,900
-15,500
-89% -$12.1M
KT icon
1440
KT
KT
$8.95B
$1.61M ﹤0.01%
118,045
+91,940
+352% +$1.21M
ENVA icon
1441
Enova International
ENVA
$6.2B
$1.61M ﹤0.01%
25,833
-111,045
-81% -$6.78M
BCE icon
1442
BCE
BCE
$20.3B
$1.6M ﹤0.01%
49,466
-130,784
-73% -$4.36M
BAX icon
1443
Baxter International
BAX
$12.6B
$1.6M ﹤0.01%
+47,810
New +$1.76M
EPR icon
1444
EPR Properties
EPR
$4.92B
$1.6M ﹤0.01%
+38,004
New +$1.56M
BZH icon
1445
Beazer Homes USA
BZH
$913M
$1.59M ﹤0.01%
57,769
+27,666
+92% +$785K
CMCAW
1446
CALL
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$1.58M ﹤0.01%
144,002
VEON icon
1447
VEON
VEON
$3.57B
$1.58M ﹤0.01%
61,001
FLS icon
1448
Flowserve
FLS
$9.38B
$1.57M ﹤0.01%
+32,676
New +$1.56M
GRPN icon
1449
Groupon
GRPN
$1.07B
$1.57M ﹤0.01%
102,696
-1,023,640
-91% -$13.7M
NN icon
1450
NextNav
NN
$1.84B
$1.57M ﹤0.01%
+193,737
New +$1.53M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.